BerGenBio ASA (0RU5.L) LSE

1.14

-0.0104(-0.91%)

Updated at August 18 09:28AM

Currency In NOK

Valuation

Market Cap288.56M
Enterprise Value149.23M
P/E Ratio-0.34
PEG Ratio-0.02
Price/Sales Ratio55.04
Price/Book Ratio0.38
Enterprise/Revenue-109.28
Enterprise/EBITDA0.68

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-164.25
Operating Margin-179.65

Management Effectiveness

Return On Assets-0.89
Return On Equity-1.02

Income Statement

Revenue848,000
Revenue/Share0.02
Gross Profit848,000
EBITDA-134.13M
Net Income-139.28M
Diluted EPS-3.95

Balance Sheet

Total Cash140.16M
Total Cash/Share3.59
Total Debt818,000
Total Debt/Equity0.01
Current Ratio4.79
Book Value Per Share3.14

Price History

52-Week Change-90.29
52-Week High5.3
52-Week Low0.08
Moving Average 50 Days0.26
Moving Average 200 Days0.51

Statistics

Average Volume238,757
Shares Outstanding39.09M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:100
Last Split DateMay 30, 2024